L-carnitine Market Size, Share & Trends Report

L-carnitine Market Size, Share & Trends Analysis Report By Process (Bioprocess, Chemical Synthesis), By Product (Food & Medicines Grade, Feed Grade), By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-3-68038-800-8
  • Number of Pages: 151
  • Format: Electronic (PDF)

Research Methodology

A three-pronged approach was followed for deducing the L-carnitine market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for L-carnitine market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of L-carnitine market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

L-carnitine Market Categorization:

The L-carnitine market was categorized into four segments, namely process (Chemical Synthesis, Bioprocess), product (Food & Pharma Grade, Feed Grade), application (Animal Feed, Healthcare Products, Functional Animal Feeds, Medicines), and region (North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa).

Segment Market Methodology:

The L-carnitine market was segmented into process, product, application, and region. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The L-carnitine market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into fifteen countries, namely, the U.S.; Canada; Mexico; Germany; the UK; France; Italy; China; India; Japan; South Korea; Brazil; Argentina; South Africa, Saudi Arabia.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

L-carnitine market companies & financials:

The L-carnitine market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Lonza -Lonza provides integrated solutions to a number of industries including pharmaceutical, biotech, consumer health, and specialty chemicals. The company operates its business through two reportable segments, namely pharma & biotech and specialty ingredients. Pharma & biotech segment focuses on clinical development services, biologics manufacturing, small-molecule businesses, and consumables & research tools. It also provides commercial contract manufacturing services through this segment

  • Northeast Pharmaceutical Group Co., Ltd. (NEPG) -Northeast Pharmaceutical Group Co., Ltd. (NEPG) operates in pharmaceutical industry through three segments, namely medical business distribution, micro-ecological preparation & western medicinal preparation, and bio-fermentation & chemical synthetic API. It is engaged in the manufacturing of 12 major product series including cerebrovascular medicines, cardiovascular medicines, narcotic medicines, digestives, anti-AIDS, antibiotics, vitamin series, etc. The company has post-doctoral workstation, QC, environmental institute, designing institute, and R&D center. Logistics center of the company handles warehousing, retail, distribution, and wholesale.

  • Biosint S.p.A. - Biosint S.p.A. is engaged in the development, manufacturing, and distribution of high value-added and technology-intensive active ingredients. The company produces L-carnitine by chemical synthesis, including derivatives & salts. The company offers a wide range of products through three segments including Biosint carnitine, pharmaceutical products, and lactic ferments. It manufactures pharmaceutical-grade carnitines and nutraceutical-grade carnitines by its patented process.

  • Cayman Chemical - Cayman Chemical is engaged in the manufacturing of recombinant proteins, antibodies, assay kits, and biochemicals. It also offers contract services for drug discovery, assay screening/development, and chemical analysis/synthesis. The company specializes in characterization, purification, and synthesis of a wide range of biochemicals. It has two subsidiaries, namely Cayman Europe located in Estonia and Cayman Pharma located in the Czech Republic.

  • Merck KGaA -Merck KGaA is a science & technology-based company and operates through three business segments: healthcare, life sciences, and performance materials. Healthcare business segment comprises two businesses, biopharma, and allergopharma. Biopharma is engaged in the development, manufacturing, and marketing of innovative pharmaceutical and biological prescription drugs to treat various disorders. Allergopharma offers high dosage, hypoallergic, and standardized preparations for allergen-specific immunotherapy.

  • Tokyo Chemical Industry Co., Ltd. - Tokyo Chemical Industry Co., Ltd. is engaged in the manufacturing and distribution of research chemicals, organic reagents, and specialty & laboratory chemicals. The company offers more than 30,000 reagents worldwide. It also manufactures fine chemicals including pharmaceutical & cosmetic raw materials and electroluminescence compounds.

  • Ceva - Ceva is engaged in research, development, production, and marketing of pharmaceutical products and vaccines for poultry, swine, livestock, and companion animals. The company boasts 25 production sites along with 12 research & development centers. The company offers products for companion animals including products for behavior, dermatology, cardio-nephrology and hypertension, and pain management.

  • Kaiyuan Hengtai Nutrition Co., Ltd. - Kaiyuan Hengtai Nutrition Co., Ltd. is engaged in research & development, production and sale of API, medical intermediates, and nutritional supplements. It boasts a strict quality management system, complete testing means, strong technical force, and advanced equipment. The products manufactured by the company are used in feed, healthcare, and food products, and are exported to countries worldwide including the Americas and Europe.

  • ChengDa PharmaCeuticals Co., Ltd. - ChengDa PharmaCeuticals Co., Ltd. is engaged in the production of APIs, food additives, feed additives, antiviral of pharmaceutical intermediates, anticancer, and antibiotics and distributes its products to over 30 countries. It operates two plants spanning across an area of 123,743 square meters.

  • Huanggang Huayang Pharmaceutical Co. Ltd. - Huanggang Huayang Pharmaceutical Co. Ltd. is a premium scientific carnitine ingredient and active pharmaceutical intermediates & intermediates manufacturer. The company is engaged in development, manufacturing, and marketing of high-quality carnitine ingredients and specialty active ingredients & intermediates for nutrition supplement, functional food and drink, pharmaceutical, and cosmetic industries.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

L-carnitine Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

L-carnitine Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon